TABLE 1.
Bacterial strains used in this study
| Strain | Characteristic(s) and/or source | MLSTa | Biotypeb | Reference |
|---|---|---|---|---|
| R652 | H. influenzae strain Rd KW20 sequenced by the TIGR | 47 | IV | 10 |
| R3001 | H. influenzae bronchoalveolar lavage of patient with cystic fibrosis | ND | II | 21a |
| R2866 | Invasive nontypeable H. influenzae; complete genome sequence available at NCBI | 99 | V | 24 |
| R2140 | H. influenzae biogroup aegyptius; CDC F3031 | ND | III | 6 |
| E1a | Hib Eagan | 44 | I | 37 |
| R538 | Reference Hib ATCC 9795 | ND | I | |
| R1513 | P. aeruginosa; ATCC 27853; quality control strain for antibiotic susceptibility testing | NA | ||
| S. aureus; UMCc clinical lab | NA | |||
| S. enterica; UMC clinical lab | NA | |||
| P. mirabilis; UMC clinical lab | NA | |||
| E. fecalis; UMC clinical lab | NA |